poisar

Stocks · News reference

UBS Maintains Hold Rating on BXP, Inc. and Lowers Price Target

Fiscal.ai

UBS analyst Michael Goldsmith has maintained a 'Hold' rating on BXP, Inc. while adjusting the price target from $70 to $66.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley FoolThe Motley Fool Team

    BXP: 3 Key Takeaways for Long-Term Investors

    Boston Properties (BXP) reported strong Q3 2026 results with occupancy reaching 89.4%, exceeding forecasts. The company raised over $520 million in asset sales to reduce debt and is benefiting from limited new office supply in premier markets, which is restoring pricing power and allowing rent increases on expiring leases. Management expects continued occupancy gains and NOI growth driven by lease expirations in coming years.

  2. Zacks Investment ResearchNa

    Healthpeak's Q3 FFOA Beat Estimates on Leasing, Senior Housing Growth

    Healthpeak Properties (DOC) reported Q3 2026 FFOA of $0.44 per share, beating estimates by 2.3%, with revenues up 16.3% YoY to $820.9 million. The company raised 2026 FFOA guidance to $1.76-$1.78 per share, supported by solid outpatient leasing, improving lab occupancy, and strong senior housing performance from Janus Living. However, operating expenses surged 30% YoY, and the company carries a Zacks Rank #4 (Sell) rating.